We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BICX market cap is 5.48M. The company's latest EPS is USD -0.2955 and P/E is -1.46.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 240k | 123k | 48k | 214k | 89k |
| Operating Income | -5.56M | -7.49M | -5.37M | -4.7M | -3.79M |
| Net Income | -6.04M | -3.47M | -5.28M | -4.37M | -3.77M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.93M | 1.83M | 820k | 767k | 389k |
| Total Liabilities | 4.99M | 6.04M | 7.78M | 8.97M | 10.34M |
| Total Equity | -1.06M | -4.21M | -6.96M | -8.2M | -9.95M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.94M | -2.15M | -3.54M | -2.04M | -1.85M |
| Investing | -122k | -9k | -50k | N/A | N/A |
| Financing | 5.43M | 106k | 3.08M | 2.03M | 1.85M |
| Market Cap | 5.48M |
| Price to Earnings Ratio | -1.46 |
| Price to Sales Ratio | 61.43 |
| Price to Cash Ratio | 84.31 |
| Price to Book Ratio | -0.55 |
| Dividend Yield | - |
| Shares Outstanding | 12.75M |
| Average Volume (1 week) | 3.58k |
| Average Volume (1 Month) | 2.85k |
| 52 Week Change | -38.57% |
| 52 Week High | 1.50 |
| 52 Week Low | 0.282 |
| Spread (Intraday) | 0.11 (22.45%) |
| Company Name | BioCorRx Inc (QB) |
| Address |
401 ryland st reno, nevada 89502 |
| Website | https://www.biocorrx.com |
| Industry | spec outpatient facility,nec (8093) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
